CN113795268B - 治疗眼疾的方法 - Google Patents
治疗眼疾的方法 Download PDFInfo
- Publication number
- CN113795268B CN113795268B CN202080025566.3A CN202080025566A CN113795268B CN 113795268 B CN113795268 B CN 113795268B CN 202080025566 A CN202080025566 A CN 202080025566A CN 113795268 B CN113795268 B CN 113795268B
- Authority
- CN
- China
- Prior art keywords
- diabetic retinopathy
- eye
- thickness
- administration
- beauvericin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828616P | 2019-04-03 | 2019-04-03 | |
| US62/828,616 | 2019-04-03 | ||
| US201962899279P | 2019-09-12 | 2019-09-12 | |
| US62/899,279 | 2019-09-12 | ||
| PCT/CN2020/082765 WO2020200241A1 (en) | 2019-04-03 | 2020-04-01 | Method for treating ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113795268A CN113795268A (zh) | 2021-12-14 |
| CN113795268B true CN113795268B (zh) | 2025-04-08 |
Family
ID=72662774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080025566.3A Active CN113795268B (zh) | 2019-04-03 | 2020-04-01 | 治疗眼疾的方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11033603B2 (https=) |
| EP (1) | EP3946414B1 (https=) |
| JP (1) | JP7461663B2 (https=) |
| KR (1) | KR20210149087A (https=) |
| CN (1) | CN113795268B (https=) |
| SG (1) | SG11202110659SA (https=) |
| TW (1) | TWI818168B (https=) |
| WO (1) | WO2020200241A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI788083B (zh) * | 2021-11-03 | 2022-12-21 | 葡萄王生技股份有限公司 | 蟬花菌絲體活性物質用於治療黃斑部病變之用途 |
| CN120936366A (zh) * | 2023-03-20 | 2025-11-11 | 资元堂生物科技股份有限公司 | 一种白殭菌素用于制备抑制血管新生药物的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0327316A (ja) * | 1989-06-23 | 1991-02-05 | Kitasato Inst:The | 高脂血症治療剤 |
| KR20080031474A (ko) * | 2005-07-27 | 2008-04-08 | 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. | 안구 질환의 치료를 위한 열충격의 사용 |
| CN101669939A (zh) * | 2009-09-22 | 2010-03-17 | 中山大学 | 恩镰孢菌素类化合物在制备抗耐药结核菌药物中的应用 |
| US20140275091A1 (en) * | 2013-03-15 | 2014-09-18 | Coyote Pharmaceuticals, Inc. | Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery |
| US20140371158A1 (en) * | 2013-06-14 | 2014-12-18 | Georgia Regents University | Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| CN109200066A (zh) * | 2017-07-07 | 2019-01-15 | 葡萄王生技股份有限公司 | 蝉花活性物质及其用于预防、延缓或治疗白内障的用途 |
-
2020
- 2020-04-01 CN CN202080025566.3A patent/CN113795268B/zh active Active
- 2020-04-01 WO PCT/CN2020/082765 patent/WO2020200241A1/en not_active Ceased
- 2020-04-01 US US16/837,259 patent/US11033603B2/en active Active
- 2020-04-01 TW TW109111356A patent/TWI818168B/zh active
- 2020-04-01 EP EP20782491.3A patent/EP3946414B1/en active Active
- 2020-04-01 JP JP2021560499A patent/JP7461663B2/ja active Active
- 2020-04-01 SG SG11202110659SA patent/SG11202110659SA/en unknown
- 2020-04-01 KR KR1020217034481A patent/KR20210149087A/ko active Pending
Non-Patent Citations (1)
| Title |
|---|
| 白僵菌素对支气管哮喘模型小鼠气道炎症的影响及其机理研究;吴刚;朱佳;朱际平;;江苏中医药;20170605(第06期);摘要 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3946414A4 (en) | 2022-12-07 |
| US20200316165A1 (en) | 2020-10-08 |
| JP7461663B2 (ja) | 2024-04-04 |
| KR20210149087A (ko) | 2021-12-08 |
| JP2022528566A (ja) | 2022-06-14 |
| WO2020200241A1 (en) | 2020-10-08 |
| TW202102252A (zh) | 2021-01-16 |
| EP3946414A1 (en) | 2022-02-09 |
| EP3946414B1 (en) | 2025-12-03 |
| CA3132137A1 (en) | 2020-10-08 |
| EP3946414C0 (en) | 2025-12-03 |
| CN113795268A (zh) | 2021-12-14 |
| US11033603B2 (en) | 2021-06-15 |
| TWI818168B (zh) | 2023-10-11 |
| SG11202110659SA (en) | 2021-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Massin et al. | Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial | |
| Audren et al. | Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg | |
| Miyake | Prevention of cystoid macular edema after lens extraction by topical indomethacin (I) A preliminary report | |
| US8097640B2 (en) | Prophylactic or therapeutic agent for diabetic maculopathy | |
| Suto et al. | A novel dual agonist of EP3 and FP receptors for OAG and OHT: safety, pharmacokinetics, and pharmacodynamics of ONO-9054 in healthy volunteers | |
| CN113795268B (zh) | 治疗眼疾的方法 | |
| KOLLARITS et al. | Norepinephrine therapy of ischemic optic neuropathy | |
| CA3132137C (en) | Method for treating ocular diseases | |
| JP4578593B2 (ja) | 糖尿病性網膜症治療のためのスロデキサイドを含有する医薬 | |
| Shin et al. | Intraocular Pressure-denpendent Retinal Vascular Change in Adult Chronic Open-angle Glaucoma Patients | |
| Ozdemir et al. | Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma | |
| Mehra et al. | Occurrence of cystoid macular edema after uneventful phacoemulsification in diabetic patients without retinopathy: a hospital-based comparative study | |
| Schilling et al. | An elusive case of cystoid macular edema | |
| Rolando et al. | Cyclosporine pharmacokinetics in healthy volunteers after ocular administration of OTX-101, a novel nanomicellar cyclosporine formulation | |
| EP3331517B1 (fr) | Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne | |
| WO2024090606A1 (ko) | 후공막염의 치료방법 | |
| Nowak et al. | Protective effect on visual functions of long-term use of trimetazidine in treatment of primary open angle glaucoma and degenerative myopia | |
| RU2356520C1 (ru) | Способ лечения постконтузионного повреждения сетчатки глаза | |
| Farag et al. | Study of Structural Changes in Diabetic Macular Edema by Spectral Domain Optical Coherent Tomography after Intravitreal Injection of Triamcinolone Acetonide | |
| Rhee et al. | The effects of Bendaline (R) on cataracts. | |
| Cameron et al. | DIABETIC RETINOPATHY AND CYANCOBALAMIN (VITAMIN B12): A PRELIMINARY REPORT | |
| Sanabria et al. | Atypical myopic retinoschisis | |
| Obiudu et al. | Central Retinal Vein Occlusion AssociatedWith Sildenafil (Viagra) | |
| JP2021134176A (ja) | ムーコル症治療薬 | |
| Upadhyay et al. | Efficiency of Fenofibrate in Facilitating the Reduction of Central Macular Thickness in Diabetic Macular Edema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |